Gilead Sciences
The Latest
-
WHO Recommends Against Use Of Remdesivir For Treating COVID-19
The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. 
The World Health Organization said that there was insufficient evidence to recommend remdesivir for treating COVID-19 patients. -
Gilead Sciences’ Remdesivir Is First FDA-Approved COVID-19 Treatment
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." 
One expert says the drug shows “modest" benefits but isn’t “a remarkable improvement." -
Remdesivir A Major Flop In Global Vaccine Test Made By WHO
But Gilead Sciences said the results did not mean the vaccine is useless. 
But Gilead Sciences said the results did not mean the vaccine is useless. -
Gilead Sciences' Remdesivir Speeds COVID Recovery Time: Study
Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. 
Remdesivir has been granted emergency use authorization by the U.S. Food and Drug Administration for treating patients hospitalized for the virus. -
Gilead Files New Drug Application With U.S. Regulator For Remdesivir
The European Union, Japan and Australia, among others, have already approved the use of remdesivir. 
The European Union, Japan and Australia, among others, have already approved the use of remdesivir. -
Regeneron COVID-19 Treatment Enters Final-Stage Trials
The tests, in tandem with the US National Institute of Allergy and Infectious Diseases, is expected to enroll 2,000 subjects. 
The tests, in tandem with the US National Institute of Allergy and Infectious Diseases, is expected to enroll 2,000 subjects. -
Britain Close To $625 Million Sanofi-Glaxo COVID-19 Vaccine Contract: Report
Over 100 candidate drugs are being formulated and tested globally to contain the pandemic. 
Over 100 candidate drugs are being formulated and tested globally to contain the pandemic. -
WHO Ends Clinical Tests Of Hydroxychloroquine Vaccine As COVID-19 Treatment
WHO is also halting trials of HIV antiretroviral drug lopinavir/ritonavir. 
WHO is also halting trials of HIV antiretroviral drug lopinavir/ritonavir. -
Remdesivir To Cost $390 Per Vial In Developed Countries
Remdesivir, the only drug approved for the treatment of COVID-19, will cost $390 per vial in developed countries. 
Remdesivir, the only drug approved for the treatment of COVID-19, will cost $390 per vial in developed countries. -
India's Drug Regulator Gives Cipla, Hetero Go Signal To Produce Remdesivir
License deal with Gilead allows remdesivir to reach low- and middle-income nations. 
License deal with Gilead allows remdesivir to reach low- and middle-income nations.
